Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · Real-Time Price · USD

22.88

-0.77 (-3.26%)

At close: Mar 24, 2026, 4:00 PM EDT

22.70

-0.18 (-0.79%)

Pre-market: Mar 25, 2026, 5:12 AM EDT

Mineralys Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-154.65	-177.81	-71.9	-29.8	-19.41
Depreciation & Amortization	0.06	0.04	-	-	-
Stock-Based Compensation	19.32	11.34	5.06	0.46	0.08
Other Adjustments	-9.88	-9.41	-6.87	-0.65	0.68
Changes in Other Operating Activities	2.73	9.52	-7.47	0.77	4.09
Operating Cash Flow	-142.42	-166.31	-81.17	-29.22	-14.56
Capital Expenditures	-0.02	-0.1	-	-	-
Purchases of Investments	-814.74	-373.45	-347.97	-71.76	-
Proceeds from Sale of Investments	425	488.5	187.5	50	-
Investing Cash Flow	-389.75	114.96	-160.47	-21.76	-
Issuance of Common Stock	591.39	116.58	203.25	-1.63	-
Net Common Stock Issued (Repurchased)	591.39	116.58	203.25	-1.63	-
Issuance of Preferred Stock	-	-	-	129.65	23.81
Net Preferred Stock Issued (Repurchased)	-	-	-	129.65	23.81
Other Financing Activities	-0.39	-0.44	-	-	-
Financing Cash Flow	591	116.14	203.25	128.02	23.81
Net Cash Flow	58.83	64.79	-38.4	77.04	9.25
Free Cash Flow	-142.43	-166.41	-81.17	-29.22	-14.56
Free Cash Flow Per Share	-2.11	-3.43	-2.24	-5.65	-2.92
Levered Free Cash Flow	-151.88	-168.34	-79.37	-29.03	-15.32
Unlevered Free Cash Flow	-167.83	-182.93	-92.13	-30.71	-14.64

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q